# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-25-038619
Filing Date
2025-08-07
Accepted
2025-08-07 08:36:25
Documents
68
Period of Report
2025-06-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | prme-20250630.htm iXBRL | 10-Q | 1041825
2 | EX-10.1 | q2202510-qex101.htm | EX-10.1 | 18330
3 | EX-10.2 | q2202510-qex102.htm | EX-10.2 | 74938
4 | EX-10.3 | q2202510-qex103.htm | EX-10.3 | 51429
5 | EX-10.4 | q2202510-qex104.htm | EX-10.4 | 103345
6 | EX-10.5 | q2202510-qex105.htm | EX-10.5 | 77328
7 | EX-10.6 | q2202510-qex106.htm | EX-10.6 | 113516
8 | EX-31.1 | q2202510-qex311.htm | EX-31.1 | 11743
9 | EX-32.1 | q2202510-qex321.htm | EX-32.1 | 7342
| Complete submission text file | 0001628280-25-038619.txt |  | 6312626

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
10 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | prme-20250630.xsd | EX-101.SCH | 39672
11 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT | prme-20250630_cal.xml | EX-101.CAL | 64924
12 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | prme-20250630_def.xml | EX-101.DEF | 229460
13 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | prme-20250630_lab.xml | EX-101.LAB | 553996
14 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | prme-20250630_pre.xml | EX-101.PRE | 390948
70 | EXTRACTED XBRL INSTANCE DOCUMENT | prme-20250630_htm.xml | XML | 754980

Mailing Address 60 FIRST ST. CAMBRIDGE MA 02141
Business Address 60 FIRST ST. CAMBRIDGE MA 02141 617-465-0013
Prime Medicine, Inc. (Filer) CIK: 0001894562 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41536 | Film No.: 251191818
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)